Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example
- PMID: 29682328
- PMCID: PMC5905834
- DOI: 10.1136/rmdopen-2018-000655
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example
Erratum in
-
Correction: Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example.RMD Open. 2018 May 14;4(1):rmdopen-2018-000655corr1. doi: 10.1136/rmdopen-2018-000655corr1. eCollection 2018. RMD Open. 2018. PMID: 29771482 Free PMC article.
Abstract
There are increasing needs for detailed real-world data on rheumatic diseases and their treatments. Clinical register data are essential sources of information that can be enriched through linkage to additional data sources such as national health data registers. Detailed analyses call for international collaborative observational research to increase the number of patients and the statistical power. Such linkages and collaborations come with legal, logistic and methodological challenges. In collaboration between registers of inflammatory arthritides in Sweden, Denmark, Norway, Finland and Iceland, we plan to enrich, harmonise and standardise individual data repositories to investigate analytical approaches to multisource data, to assess the viability of different logistical approaches to data protection and sharing and to perform collaborative studies on treatment effectiveness, safety and health-economic outcomes. This narrative review summarises the needs and potentials and the challenges that remain to be overcome in order to enable large-scale international collaborative research based on clinical and other types of data.
Keywords: autoimmune diseases; dmards (biologic); epidemiology.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- Glintborg B, Gudbjornsson B, Krogh NS, et al. Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO. Rheumatology 2014;53:2100–9. 10.1093/rheumatology/keu252 - DOI - PubMed
-
- Twigg S, Hensor EMA, Freeston J, et al. Fatigue, older age, higher body mass index and female gender predict worse disability in early rheumatoid arthritis despite treatment to target: a comparison of two observational cohort studies from the United Kingdom. Arthritis Care Res (Hoboken) 2017.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous